Thrilled to represent Hyloris at #iDR24.
Eager to dive into discussions and explore partnerships to address unmet needs by reinventing excisting medications!
Together, we will make a difference for patients.
#REMEDI4ALL#DrugRepurposing#Hyloris
Dat was het dan!
Na vier jaar onderzoek heb ik afgelopen dinsdag mijn doctoraat in de biomedische wetenschappen behaald. Wat een mooi moment! Énorm dankbaar voor alle fantastische mensen op me heen.
Presented our poster “The dynamics of nucleotide variants in the progression from myeloma precursor conditions to multiple myeloma using targeted sequencing of serial bone marrow samples” at the 18th International Myeloma Workshop.
#IMW2021#IMW21#IMS#mmsm@Myeloma_Society
Looking forward to attending the 18th International Myeloma Workshop within a few weeks in Vienna and present our latest results during the Poster sessions. #IMW2021#mmsm#MGUS#MultipleMyeloma@Myeloma_Society 🧬👩🔬
Recently published work by @BenedithOben, @FrancescoMaura4 and @DrOlaLandgren shows that myeloma precursors that do not progress to multiple myeloma have a distinct genomic profile and emerge later in the patient's life
#CancerResearch @NatResCancer
Check out our last paper on MGUS and SMM in @NatureComms: "Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities"@SylvesterCancer@UMiamiHealth @sloan_kettering @LaStatale@uhasselt#mmsm https://t.co/ArUtYkRrg9 👇👇(1/18)